Skip to main content
. 2022 Sep 14;23:775. doi: 10.1186/s13063-022-06493-5

Table 4.

Expected precision around the given immune response (seroconversion or fourfold titre/concentration rise) rate estimates in adults and toddler/infants who will receive MRV-MNP

Immune response rate in sample (%) n = 30 n = 60
Immune response (%) (95% CI) Immune response (%) (95% CI)
20.0 20.0 (9.5–37.3) 20.0 (11.8–31.8)
40.0 40.0 (24.6–57.7) 40.0 (28.6–52.6)
60.0 60.0 (42.3–75.4) 60.0 (47.4–71.4)
80.0 80.0 (62.7– 90.5) 80.0 (68.2–88.2)
100.0 100.0 (88.7–100.0) 100.0 (94.0–100.0)